Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.

× No keyword cloud information.

13 in total

Review 1. Xanthines as adenosine receptor antagonists.

Authors: Christa E Müller; Kenneth A Jacobson
Journal: Handb Exp Pharmacol Date: 2011

2. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.

Authors: R A Cunha; B Johansson; M D Constantino; A M Sebastião; B B Fredholm
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1996-02 Impact factor: 3.000

3. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats.

Authors: S Satoh; H Matsumura; F Suzuki; O Hayaishi
Journal: Proc Natl Acad Sci U S A Date: 1996-06-11 Impact factor: 11.205

Review 4. A_2A Adenosine Receptor Antagonists in Neurodegenerative Diseases.

Authors: Stefania Merighi; Pier A Borea; Katia Varani; Fabrizio Vincenzi; Kenneth A Jacobson; Stefania Gessi
Journal: Curr Med Chem Date: 2022 Impact factor: 4.740

5. Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

Authors: H O Kim; X D Ji; N Melman; M E Olah; G L Stiles; K A Jacobson
Journal: J Med Chem Date: 1994-11-11 Impact factor: 7.446

6. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.

Authors: S Dionisotti; A Conti; D Sandoli; C Zocchi; F Gatta; E Ongini
Journal: Br J Pharmacol Date: 1994-06 Impact factor: 8.739

7. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

Authors: C Zocchi; E Ongini; S Ferrara; P G Baraldi; S Dionisotti
Journal: Br J Pharmacol Date: 1996-04 Impact factor: 8.739

Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.

Review 1. Xanthines as adenosine receptor antagonists.

2. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.

3. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats.

Review 4. A_2A Adenosine Receptor Antagonists in Neurodegenerative Diseases.

5. Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

6. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.

7. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

8. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

Review 9. Progress in the pursuit of therapeutic adenosine receptor antagonists.

10. Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.

Review 1. Xanthines as adenosine receptor antagonists.

Review 4. A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases.

Review 9. Progress in the pursuit of therapeutic adenosine receptor antagonists.

Review 4. A_2A Adenosine Receptor Antagonists in Neurodegenerative Diseases.